对影响我国ST段抬高型急性心肌梗死患者院内死亡因素的再认识

发布时间：2018-05-04 12:09

  本文选题：心肌梗死 + 医院死亡率　； 参考：《解放军医学杂志》2016年06期

【摘要】：预测ST段抬高型心肌梗死(STEMI)患者院内死亡风险对于指导临床医生选择合理治疗方案至关重要。本期刊登的四篇文章深入分析了近年我国军队医院冠心病介入治疗数据库的资料,分别从性别、心肌梗死靶血管术前闭塞程度、单中心规范化胸痛中心建设、应用主动脉内球囊反搏治疗方面探讨了STEMI患者院内死亡的影响因素,这将有助于临床医生制定个体化治疗方案、进一步优化再灌注策略、提高临床疗效和改善患者预后。
[Abstract]:Predicting the risk of hospital death in patients with ST-segment elevation myocardial infarction (STEMI) is essential to guide clinicians to choose a reasonable treatment plan. Four articles published in this issue have thoroughly analyzed the data of coronary intervention treatment database in military hospitals in China in recent years, from gender, degree of occlusion of target vessels in myocardial infarction before operation, construction of standardized chest pain center with single center. In the aspect of intra-aortic balloon counterpulsation, the factors influencing hospital mortality in patients with STEMI were discussed, which would be helpful for clinicians to formulate individualized treatment plan, further optimize reperfusion strategy, improve clinical efficacy and improve prognosis of patients.
【作者单位】： 沈阳军区总医院全军心血管病研究所心内科;
【分类号】：R542.22
，

本文编号：1843001